Prophylactic Effects of Sulforaphane on Depression-like Behavior and Dendritic Changes in Mice After Inflammation
Overview
Nutritional Sciences
Authors
Affiliations
Inflammation plays a role in the pathophysiology of depression. Sulforaphane (SFN), an isothiocyanate compound derived from broccoli, is a potent activator of the NF-E2-related factor-2 (Nrf2), which plays a role in inflammation. In this study, we examined whether the prevention effects of SFN in lipopolysaccharide (LPS) induced depression-like behavior in mice. Pretreatment with SFN significantly blocked an increase in the serum tumor necrosis factor-α (TNF-α) level and an increase in microglial activation of brain regions after a single administration of LPS (0.5 mg/kg). Furthermore, SFN significantly potentiated increased serum levels of IL-10 after LPS administration. In the tail-suspension test and forced swimming test, SFN significantly attenuated an increase of the immobility time after LPS administration. In addition, SFN significantly recovered to control levels for LPS-induced alterations in the proteins such as brain-derived neurotrophic factor, postsynaptic density protein 95 and AMPA receptor 1 (GluA1) and dendritic spine density in the brain regions. Finally, dietary intake of 0.1% glucoraphanin (a glucosinolate precursor of SFN) food during the juvenile and adolescence could prevent the onset of LPS-induced depression-like behaviors and dendritic spine changes in the brain regions at adulthood. In conclusion, these findings suggest that dietary intake of SFN-rich broccoli sprout has prophylactic effects on inflammation-related depressive symptoms. Therefore, supplementation of SFN-rich broccoli sprout could be prophylactic vegetable to prevent or minimize the relapse by inflammation in the remission state of depressed patients.
Ramakrishnan M, Fahey J, Zimmerman A, Zhou X, Panjwani A Front Nutr. 2024; 11:1448130.
PMID: 39421616 PMC: 11484503. DOI: 10.3389/fnut.2024.1448130.
Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane.
Habtemariam S Biomedicines. 2024; 12(6).
PMID: 38927376 PMC: 11200786. DOI: 10.3390/biomedicines12061169.
Genetic contribution to microglial activation in schizophrenia.
Koskuvi M, Porsti E, Hewitt T, Rasanen N, Wu Y, Trontti K Mol Psychiatry. 2024; 29(9):2622-2633.
PMID: 38519640 PMC: 11420079. DOI: 10.1038/s41380-024-02529-1.
Jafari R, Behrouz V Front Nutr. 2023; 10:1215358.
PMID: 37645628 PMC: 10461010. DOI: 10.3389/fnut.2023.1215358.
The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies.
Sani G, Margoni S, Brugnami A, Ferrara O, Bernardi E, Simonetti A Antioxidants (Basel). 2023; 12(4).
PMID: 37107192 PMC: 10135298. DOI: 10.3390/antiox12040817.